Literature DB >> 21224118

Interobserver consistency of digital rectal examination in clinical staging of localized prostatic carcinoma.

J C Angulo1, J E Montie, T Bukowsky, A Chakrabarty, D J Grignon, W Sakr, F H Shamsa, J Edson Pontes.   

Abstract

A prospective study was undertaken to determine the reproducibility of clinical staging based on digital rectal examination (DRE) in prostate carcinoma. We evaluated 48 consecutive patients diagnosed with localized prostatic cancer. Four urologists performed DRE and sorted the patients according to the 1992 American Joint Committee on Cancer Classification for prostate cancer. Both the percentage observed total agreement among each couple of two different observers and the interobserver variability (Kappa index) were analyzed. The percentage observed total agreement among observers in distinguishing five clinical subcategories (T1c, T2a, T2b, T2c, and T3a) ranged between 38-60% (mean 49%) and the Kappa index showed interobserver agreement was poor (overall Kappa = 0.3 1). All four examiners agreed in assigning the same subcategory in only 21 % of cases, and 90% of them were T I. If only categories are distinguished (T I, T2, or T3), the percentage observed total agreement rises to 60-71% (mean 66%) and the interexaminer agreement improves to good (overall Kappa = 0.4 1). Accurate pathologic staging was obtained in every patient and the percentage observed agreement between every examiner and the pathologist was calculated, excluding cases interpreted as T I c. Regarding subcategories, clinicopathologic agreement ranges between 17-46%. If only categories T2 and9T3 are distinguished, agreement rises to 57-69%. In summary, the ability to reproduce clinical staging based on DRE among multiple examiners is disappointingly low and understandably correlates poorly with pathologic stage.

Entities:  

Year:  1995        PMID: 21224118     DOI: 10.1016/1078-1439(95)00066-6

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  2 in total

1.  Prognostic Value of Pretreatment MRI in Patients With Prostate Cancer Treated With Radiation Therapy: A Systematic Review and Meta-Analysis.

Authors:  Sungmin Woo; Sangwon Han; Tae-Hyung Kim; Chong Hyun Suh; Antonio C Westphalen; Hedvig Hricak; Michael J Zelefsky; Hebert Alberto Vargas
Journal:  AJR Am J Roentgenol       Date:  2019-12-04       Impact factor: 3.959

2.  Clinical stage provides useful prognostic information even after pathological stage is known for prostate cancer in the PSA era.

Authors:  Maxine M Chen; Jaquelyn L Jahn; John R Barber; Misop Han; Meir J Stampfer; Elizabeth A Platz; Kathryn L Penney
Journal:  PLoS One       Date:  2020-06-11       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.